Analyst Ratings for Nightstar Therapeutics (NITE)

NITE Rating Summary

  |   Expand Research on NITE
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 2 / 10   Percentile Rank: 15%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/25/2019 Barclays Gena Wang Downgrade Equalweight
(Overweight)
26.00
(28.00)
25.31
(35.12)
38.76% Details
3/5/2019 UBS N/A Downgrade Neutral
(Buy)
25.50
(21.00)
15.16
(35.12)
131.66% Details